Findings in human livers reconciled the in-vitro and in-vivo studies, where survivin was highly expressed in the livers of patients with HCC as compared with normal subjects, patients with NASH, or patients with liver metastasis. The gene discussed is BIRC5; the disease is metabolic dysfunction-associated steatohepatitis.